Medix Medical Systems Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 03-12-2024
- Paid Up Capital ₹ 0.60 M
as on 03-12-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 15.76%
(FY 2019)
- Profit -810.40%
(FY 2019)
- Ebitda -149.13%
(FY 2019)
- Net Worth -93.48%
(FY 2019)
- Total Assets 96.66%
(FY 2019)
About Medix Medical Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Srinivasan Ragothaman and Nagaveni Ragothaman serve as directors at the Company.
- CIN/LLPIN
U29118KA2006PTC040881
- Company No.
040881
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medix Medical Systems Private Limited offer?
Medix Medical Systems Private Limited offers a wide range of products and services, including Phototherapy Unit, Shockwave Therapy Equipment, Forceps & Graspers, Electrosurgical Unit, Medical Surgery & Treatment Centres, Medical Treatment Services, Lithotripsy System, Physiotherapy & Rehab Aids, Urological & Obstetrics Instruments, Urology Equipment.
Who are the key members and board of directors at Medix Medical Systems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasan Ragothaman  | Director | 08-Nov-2006 | Current |
| Nagaveni Ragothaman | Director | 23-Sep-2009 | Current |
Financial Performance of Medix Medical Systems.
Medix Medical Systems Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 15.76% increase. The company also saw a substantial fall in profitability, with a 810.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 93.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medix Medical Systems?
In 2019, Medix Medical Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Regenta Biodiagnostics India Private LimitedActive 4 years 11 months
Srinivasan Ragothaman is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medix Medical Systems?
Unlock and access historical data on people associated with Medix Medical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medix Medical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medix Medical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
